GRCE Projected Dividend Yield
Grace Therapeutics Inc ( NASDAQ : GRCE )Acasti Pharma Inc. is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Co.'s therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of more than 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104 is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. 21 YEAR PERFORMANCE RESULTS |
GRCE Dividend History Detail GRCE Dividend News GRCE Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |